Search engine for other government resources

Irbesartan MedlinePlus Drug Information

Irbesartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain natural substances that ...
medlineplus.gov/druginfo/meds/a698009.html

Irbesartan C25H28N6O - PubChem

Irbesartan is an angiotensin II receptor blocker used alone or in combination with other agents in the therapy of hypertension and diabetic ...
pubchem.ncbi.nlm.nih.gov/compound/irbesartan

DailyMed - IRBESARTAN tablet

Irbesartan USP is a white to off-white crystalline powder with a molecular weight of 428.5. It is a nonpolar compound with a partition coefficient ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=33416f1e-adee-4a45-b6fe-1fc39044e307

Comparison of the antihypertensive efficacy of irbesartan ...

This analysis aimed to explore whether low-dose irbesartan/hydrochlorothiazide (HCTZ) has superior blood pressure (BP)-lowering efficacy over low-dose ...
pubmed.ncbi.nlm.nih.gov/21091220/

Irbesartan review of pharmacology and comparative ...

Irbesartan is well absorbed, does not require biotransformation to an active metabolite to exert its antihypertensive activity, offers a large volume ...
pubmed.ncbi.nlm.nih.gov/10822210/

Clinical overview of irbesartan expanding the therapeutic ...

Irbesartan: Irbesartan, a new angiotensin II receptor antagonist, has been shown to provide significant blood pressure reductions compared with ...
pubmed.ncbi.nlm.nih.gov/9532518/

Irbesartan a comprehensive profile - PubMed

Irbesartan exerts its action mainly via a selective blockade action on AT1 receptors and the consequent reduced pressor effect of angiotensin II. This ...
pubmed.ncbi.nlm.nih.gov/33461698/

Long-term use and tolerability of irbesartan for control ...

Irbesartan (Aprovel , Avapro , Irbetan , Karvea ) is a well established angiotensin receptor blocker, approved worldwide for the treatment of ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC3172075/

Drug interactions with irbesartan - PubMed

Irbesartan is an angiotensin II receptor antagonist indicated for the treatment of patients with hypertension. Although irbesartan does not require ...
pubmed.ncbi.nlm.nih.gov/11523726/

Effects of doxazosin and irbesartan on blood pressure and ...

Irbesartan had significantly better antihypertensive efficacy than doxazosin (P < 0.05). Doxazosin had the greatest effect on glucose metabolism and ...
pubmed.ncbi.nlm.nih.gov/15897788/

Effect of irbesartan on erectile function in patients with ...

The angiotensin receptor antagonist irbesartan has been shown to improve endothelial function in cardiovascular high-risk patients, which suggests a ...
pubmed.ncbi.nlm.nih.gov/18596705/

Irbesartn MedlinePlus medicinas

Su doctor probablemente le dir que no tome irbesartan si usted tiene diabetes y tambin est tomando aliskiren. Informe a su mdico y a su ...
medlineplus.gov/spanish/druginfo/meds/a698009-es.html

DailyMed - Search Results for IRBESARTAN

IRBESARTAN AND HYDROCHLOROTHIAZIDE tablet IRBESARTAN AND HYDROCHLOROTHIAZIDE tablet, film coated. NDC Code(s): 62332-051-10, 62332-051-30, ...
dailymed.nlm.nih.gov/dailymed/search.cfm?query=IRBESARTAN

Irbesartan Tablets USP

Irbesartan USP is a white to off-white crystalline powder with a molecular weight of 428.5. It is a nonpolar compound with a partition coefficient ...
dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=2a7cc4e3-bf9e-6d21-e054-00144ff8d46c

Effects of aerobic exercise training and irbesartan on ...

Background and objectives: The present pilot study was undertaken to evaluate the efficacy of an aerobic exercise training (AET) program alone or ...
pubmed.ncbi.nlm.nih.gov/18949104/

DailyMed - IRBESARTAN tablet

Irbesartan USP is a white to off-white crystalline powder with a molecular weight of 428.5. It is a nonpolar compound with a partition coefficient ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8635a1c-ae06-4e23-99f7-e704f91d6f43

Pharmaceutical compositions containing irbesartan - Patent ...

DESAI DIVYAKANT S (US) Assignee. BRISTOL MYERS SQUIBB CO (US) Date. Priority. 1995/06/07. This web page summarizes information in PubChem about patent ...
pubchem.ncbi.nlm.nih.gov/patent/NO-962387-D0

Renal protective effect of SGLT2 inhibitor dapagliflozin ...

Combination of dapagliflozin and irbesartan produced more remarkable protective effects on renal function and structure, than use of either agent ...
pubmed.ncbi.nlm.nih.gov/29635129/

Modeling of the pharmacokineticpharmacodynamic ...

Irbesartan plus hydrochlorothiazide had a greater blood pressure lowering effect compared with irbesartan alone, despite the unchanged irbesartan PK ...
pubmed.ncbi.nlm.nih.gov/25545238/

PDF AVAPRO

Irbesartan is a white to off-white crystalline powder with a molecular weight of 428.5. It is a nonpolar compound with a partition coefficient ...
www.accessdata.fda.gov/drugsatfda_docs/label/2014/020757s064lbl.pdf